In addition, both glycolysis and aldehyde dehydrogenase (ALDH) activity were significantly elevated in mesenchymal GSCs but not in proneural GSCs, which makes targeting the ALDH signaling pathway a potential approach for glioma treatment. Here, LDHA is linked to central nervous system cancer.